Your knees work hard to get you from place to place, and they’re generally quiet about it—that is until things start going wrong. Knee pain is, unfortunately, a common problem for Americans of all ages.
According to the Centers for Disease Control and Prevention, more than 15 million people say they have severe joint pain from arthritis alone. But other injuries and conditions can put your knees in peril, too, including tendonitis, fractures and tears, obesity and arthritis.
When to see a Knee Specialist?
Many patients delay treatment for knee pain out of fear and worry about surgery, living years with unnecessary pain and discomfort. Yet, surgery isn’t always the answer.
“We limit our practice to treating knee injuries and knee disorders,” says Dr. Jeffrey H. DeClaire, Orthopaedic Knee Specialist at Michigan Knee Institute in Rochester Hill, Michigan. “We do a complete evaluation of the patient’s knee, looking at non-operative methods first, allowing us to determine the best course of treatment and to get patients back in the game of life in a shorter period of time.”
Hour Detroit Top Docs 2021
London, UK-based Corin has announced that its OMNIBotics robotic-assisted platform has recently completed 25,000 total knee arthroplasties (TKA), including 5,000 procedures using the company’s BalanceBot ligament balancing robotic device.
Jeffrey H. DeClaire, M.D. of the DeClaire LaMacchia Orthopedic Institute, in Rochester, Michigan, is one of the first orthopedic surgeons to use BalanceBot. In his opinion, “OMNIBotics, and the use of the BalanceBot device, is a significant improvement to the field of knee replacement. The ability to plan implant position to best balance the knee’s soft tissues using the Predictive Balance software, on top of the consistency and reproducibility that comes with robotics, is remarkable. The immediate results are noticeable and I’m excited to continue monitoring my patients and track their recoveries.”
1,000 Cases Completed with First Predictive Ligament Balancing Robot
AYNHAM, Mass., Oct. 3, 2018 /PRNewswire/ — OMNIlife science, Inc. (“OMNI”), a privately-held, medical technology company targeting the $15 billion global hip and knee replacement device market, reported today that the positive clinical benefits of the OMNIBotics® Robotic Active Spacer continue to be reinforced by more than 1,000 successful procedures performed to date. Orthopaedic surgeons have been evaluating this revolutionary system that utilizes a miniature robot to ensure the ligaments will be “balanced” after the knee replacement.
Please Join us for a Candid Discussion on Options in Total Knee Replacement – Given by Dr. Jeffrey H. DeClaire, MD
Jeffrey H. DeClaire, M.D. is a board-certified and fellowship-trained orthopaedic surgeon. Dr. DeClaire has practiced orthopaedic surgery in Rochester, MI for more than 25 years and specializes in the treatment of disorders and injuries of the knee. He is the Co-Founder and President of the DeClaire LaMacchia Orthopaedic Institute, the Chief of the Department of Orthopaedics and Surgery at Ascension Providence Rochester Hospital and is an associate clinical professor at Oakland University in Rochester Hills, MI. Dr. DeClaire is an industry leader in bringing new technologies for the treatment and benefit of his patients.
As Apple pushes deeper into health care with the Apple Watch, the company is developing a plan to help people who are recovering from knee and hip replacement surgeries.